APVO icon

Aptevo Therapeutics
APVO

Overview Fund Trends Analyst Outlook Journalist POV

9 hedge funds and large institutions have $37.4M invested in Aptevo Therapeutics in 2018 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

more capital invested

Capital invested by funds: $ → $

more funds holding

Funds holding: →

less ownership

Funds ownership: →

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

Holders
9
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$2.5M
2
+$1.91M
3
+$1.83M

Top Sellers

1
-$7.78M
2
-$703K
3
-$647K
4
AIM
Alambic Investment Management
California
-$646K
5
OAM
Oxford Asset Management
United Kingdom
-$460K
Name Holding Trade Value Shares
Change 		Change in
Stake
51
$10K
52
$3K
53
$2K
54
$2K
55
$2K
56
$1K
57
$499
58
$225
59
$35
60
–
61
–
62
–
63
–
64
–
1 2
3